Evaluation of Maxillary and Mandibulary Nerve Blocks on Morphine Consumption
- Conditions
- Dento Facial Dysmorphism
- Interventions
- Procedure: Maxillary and mandibular blocksProcedure: General anesthesia
- Registration Number
- NCT03299998
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Background and Objectives: Double-jaw surgery is one of the most painful oral surgery, requiring multimodal analgesia including controlled morphine pump and its secondary effects. The aim of this study was to evaluate the effectiveness of face block (mandibulary and maxillary block analgesia) on the first 24 hours on morphine consumption in patients admitted for double jaw surgery.
- Detailed Description
Methods: Patients undergoing double-jaw surgery between January 2015 and May 2017 were enrolled. Patients were separated into 2 groups: patients receiving maxillary-mandibulary nerve block and those no receiving it. The primary endpoint was the morphine consumption within 24 hours post-surgery. Secondary endpoints were the intra-operative remifentanil consumption, incidence of postoperative nausea and vomiting at 24 hours, morphine consumption in recovery room, length of stay in hospital.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Not specified
- Target Recruitment
- 92
- Male and female who underwent double jaw surgery
- opposition to the study
- an additional surgical procedure
- preoperative consumption of morphine or derived from morphine
- perioperative N20
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description BLOCK+ General anesthesia Patients who underwent maxillary and mandibulary block before surgery BLOCK - General anesthesia Patients who did not undergo maxillary and mandibulary block before surgery. BLOCK+ Maxillary and mandibular blocks Patients who underwent maxillary and mandibulary block before surgery
- Primary Outcome Measures
Name Time Method Cumulative morphine consumption within 24 hours post-surgery 24 hours Cumulative morphine consumption measured using patient controlled analgesia (PCA-pump).
- Secondary Outcome Measures
Name Time Method Peroperative remifentanil consumption End of surgery (2 hours in average) Remifentanil consumption in µg.kg-1 during surgery
Cumulative morphine consumption within 12 hours post-surgery 12 hours Cumulative morphine consumption measured using patient controlled analgesia (PCA-pump).
Hospital length of stay Up to hospital discharge (5 days in average) Delay between hospitalization date and date of hospital discharge
Cumulative morphine consumption within 48 hours post-surgery 48 hours Cumulative morphine consumption measured using patient controlled analgesia (PCA-pump).
Trial Locations
- Locations (1)
Hospices Civils de Lyon
🇫🇷Lyon, France